Proof-of-concept Study of New Imaging Diagnostic in Patients With Suspected Alzheimer's Disease (clinicaltrials.gov) - Dec 2, 2022 - P1 | N=18 | Recruiting | Sponsor: Alzeca Biosciences, Inc. | Initiation date: Jul 2022 ➔ Nov 2022
First-in-human • Trial initiation date • Alzheimer's Disease • CNS Disorders
|